| 000 | 01811 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513132950.0 | ||
| 264 | 0 | _c19980305 | |
| 008 | 199803s 0 0 eng d | ||
| 022 | _a1040-8401 | ||
| 024 | 7 |
_a10.1615/critrevimmunol.v18.i1-2.70 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRivoltini, L | |
| 245 | 0 | 0 |
_aRecognition of melanoma-derived antigens by CTL: possible mechanisms involved in down-regulating anti-tumor T-cell reactivity. _h[electronic resource] |
| 260 |
_bCritical reviews in immunology _c1998 |
||
| 300 |
_a55-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Viral _ximmunology |
| 650 | 0 | 4 |
_aCancer Vaccines _ximmunology |
| 650 | 0 | 4 |
_aDown-Regulation _ximmunology |
| 650 | 0 | 4 |
_aEpitopes _ximmunology |
| 650 | 0 | 4 |
_aEpitopes, T-Lymphocyte _ximmunology |
| 650 | 0 | 4 |
_aHLA-A1 Antigen _ximmunology |
| 650 | 0 | 4 |
_aHLA-A2 Antigen _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization |
| 650 | 0 | 4 | _aMART-1 Antigen |
| 650 | 0 | 4 |
_aMelanoma _ximmunology |
| 650 | 0 | 4 |
_aNeoplasm Proteins _ximmunology |
| 650 | 0 | 4 |
_aPeptides _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 650 | 0 | 4 | _aVaccination |
| 700 | 1 | _aLoftus, D J | |
| 700 | 1 | _aSquarcina, P | |
| 700 | 1 | _aCastelli, C | |
| 700 | 1 | _aRini, F | |
| 700 | 1 | _aArienti, F | |
| 700 | 1 | _aBelli, F | |
| 700 | 1 | _aMarincola, F M | |
| 700 | 1 | _aGeisler, C | |
| 700 | 1 | _aBorsatti, A | |
| 700 | 1 | _aAppella, E | |
| 700 | 1 | _aParmiani, G | |
| 773 | 0 |
_tCritical reviews in immunology _gvol. 18 _gno. 1-2 _gp. 55-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1615/critrevimmunol.v18.i1-2.70 _zAvailable from publisher's website |
| 999 |
_c9389021 _d9389021 |
||